Product Details for NDA 203858
JUXTAPID (LOMITAPIDE MESYLATE)
EQ 5MG BASE
Marketing Status: Prescription
EQ 10MG BASE
Marketing Status: Prescription
EQ 20MG BASE
Marketing Status: Prescription
EQ 30MG BASE
Marketing Status: Prescription
EQ 40MG BASE
Marketing Status: Discontinued
EQ 60MG BASE
Marketing Status: Discontinued
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: LOMITAPIDE MESYLATE
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 001
Approval Date: Dec 21, 2012
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
JUXTAPID (LOMITAPIDE MESYLATE)
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 001
Approval Date: Dec 21, 2012
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: LOMITAPIDE MESYLATE
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 002
Approval Date: Dec 21, 2012
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
JUXTAPID (LOMITAPIDE MESYLATE)
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 002
Approval Date: Dec 21, 2012
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 20MG BASE
Marketing Status: Prescription
Active Ingredient: LOMITAPIDE MESYLATE
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 003
Approval Date: Dec 21, 2012
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
JUXTAPID (LOMITAPIDE MESYLATE)
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 003
Approval Date: Dec 21, 2012
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 30MG BASE
Marketing Status: Prescription
Active Ingredient: LOMITAPIDE MESYLATE
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 30MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 004
Approval Date: Apr 23, 2015
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
JUXTAPID (LOMITAPIDE MESYLATE)
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 30MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 004
Approval Date: Apr 23, 2015
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 40MG BASE
Marketing Status: Discontinued
Active Ingredient: LOMITAPIDE MESYLATE
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 005
Approval Date: Apr 23, 2015
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Discontinued
Patent and Exclusivity Information
JUXTAPID (LOMITAPIDE MESYLATE)
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 005
Approval Date: Apr 23, 2015
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 60MG BASE
Marketing Status: Discontinued
Active Ingredient: LOMITAPIDE MESYLATE
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 006
Approval Date: Apr 23, 2015
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: JUXTAPID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203858
Product Number: 006
Approval Date: Apr 23, 2015
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status: Discontinued
Patent and Exclusivity Information